medigraphic.com
SPANISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2002, Number 1

<< Back Next >>

salud publica mex 2002; 44 (1)

Is the hemorrhagic disease of the newborn re-emerging? Issues related to its prevention.

Newton-Sánchez OA, Basurto-Celaya G, Richardson V, Belkind-Gerson J
Full text How to cite this article

Language: Spanish
References: 9
Page: 57-59
PDF size: 30.16 Kb.


Key words:

hemorrhagic disease of newborn, vitamin K, Mexico.

ABSTRACT

Objective. To describe the occurrence of hemorrhagic disease of the newborn (HDN) at a tertiary care pediatric hospital of Morelos state. Material and Methods. A retrospective case series study was conducted between 1997- 2000 at Hospital del Niño Morelense (Morelos State Children’s Hospital), in 46 newborns aged under 12 weeks. Study subjects were referred from peripheral units with a diagnosis of HDN. Results. The severe late-onset form of HDN was present in 91% of the cases. Fifty-two percent of childbirths were assisted by a physician and 48% by an empiric midwife. Application of vitamin K was unknown in 61% of cases, in 39% it was not applied and in 4% it was applied. The majority of infants presented severe symptoms due to intra-cranial bleeding, 11% died, and 41% had severe disease sequelae. Conclusions. Given the high prevalence of HDN in the State of Morelos, reproductive health programs should be reviewed and training programs intensified to promote the utilization of vitamin K by physicians and nurses for preventing this disease.


REFERENCES

  1. Townsend CV. The hemorrhage diseases of the newborn. Arch Pediatr 1894;11:559.

  2. Victora CG, Van Haecke P. Vitamin K prophylaxis in less developed countries: Policy issues and relevance to breastfeeding promotion. Am J Public Health 1988;88(2):203-209.

  3. Segel George B. Hematology of the newborn. En: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Williams Hematology, ed. Fifth edition. MacGraw- Hill. Nueva York, USA, 1995.

  4. Zipursky A. Prevention of vitamin K deficiency bleeding in newborns. Br J Haematol 1999;101(3):130-137.

  5. Solves P, Altes A, Ginovart G, Demestre J, Fontcuberta J. Late hemorrhage disease of the newborn as a cause of intracerebral bleeding. Ann Hematol 1997;75(1-2):65-66.

  6. Organización Panamericana de la Salud, (OPS). Organización Mundial de la Salud, (OMS). Clasificación estadística internacional de enfermedades y problemas relacionados con la salud. Décima edición. Washington, D.C.: OPS 1995, vol. 1.

  7. McNinch AW, Tripp JH. Haemorrhagic disease of the newborn in the British Isles: Two years prospective study. BMJ 1991;303(6810):1105-1109.

  8. McMillan Douglas D. Administration of vitamin K to newborns: Implications and recommendations. CMAJ 1996;154:347-349.

  9. Loughnan PM, McDougall PN. Epidemiology of late onset hemorrhage disease: A pooled data analysis. J Paediatr Child Health 1993;29:177-181.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2002;44